查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540887

2024-2032 年按产品类型、产品（Symplicity、Vessix、EnligHTN、Paradise、Iberis 等）、技术、应用、最终用户和地区分類的肾去神经系统市场报告

Renal Denervation Systems Market Report by Product Type, Product (Symplicity, Vessix, EnligHTN, Paradise, Iberis, and Others), Technology, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球肾去神经系统市场规模达到4.438亿美元。该市场是由高血压盛行率上升、治疗方法的技术进步以及证明疗效的广泛临床试验所推动的。医院和诊断中心正在广泛采用这些系统，再加上策略合作和监管部门的批准，进一步推动了市场的成长。

去肾神经系统市场分析：

主要市场驱动因素：市场主要受到高血压和抗药性高血压发病率上升的推动，这推动了对有效治疗的需求。基于导管和非侵入性方法的技术进步提高了治疗效率和安全性，从而促进了治疗的采用。验证长期效益的广泛临床试验进一步促进了市场成长。人们越来越重视改善患者治疗效果和管理慢性病，凸显了去肾臟神经系统市场的成长。

主要市场趋势：主要市场趋势包括各种技术创新，例如先进的基于导管的系统和非侵入性系统，可提高整体功效和安全性。临床试验的逐渐增加正在验证长期效益，进一步促进更广泛的接受。批准正在加速市场进入，而策略合作则正在加强研发力度。高血压发病率的上升也对去肾神经系统市场的成长做出了积极贡献。

地理趋势：市场的地理趋势显示欧洲的显着采用和成长通常是由其先进的医疗基础设施和有利的监管环境所推动的。北美地区也在逐渐扩张，这主要是由于高血压盛行率的上升和各种技术的进步。由于医疗保健投资的增加和消费者意识的提高，亚太地区的市场活动显着增加。拉丁美洲和中东是具有医疗保健系统成长潜力的新兴市场。

竞争格局：去肾神经系统产业的一些主要市场参与者包括 Boston Scientific Group、Kona Medical Inc.、Medtronic Plc、Mercator MedSystems、ReCor Medical Inc.（Otsuka Holdings Co. Ltd.）、Renal Dynamics、St. Jude Medical Inc. (Abbott) 和Terumo Corporation 等。

挑战与机会：市场面临各种挑战，如高成本、监管障碍和需要广泛的临床试验。然而，它也带来了机会，例如技术进步、抗药性高血压增加导致的需求增加以及新兴市场医疗保健基础设施的扩大。策略合作和有利的监管发展进一步增强了成长潜力，同时人们对去肾神经支配益处的认识不断提高，可以推动去肾神经支配系统市场在全球的成长和渗透。

去肾神经系统市场趋势：

临床试验不断增加

越来越多的临床试验对于肾臟去神经术市场至关重要，因为它们提供了有关该手术的长期益处和安全性的重要资料。这些试验有助于确定肾去神经术在治疗高血压方面的功效，从而赢得医疗保健提供者和患者的信心。成功的试验结果会获得监管部门的批准，进一步推动产品的采用。此外，临床试验透过突出需要改进的领域和验证新技术来促进创新，最终支持市场的成长和扩张。例如，2023 年 11 月，FDA 批准了一种超音波肾去神经装置 Paradise 系统，用于治疗对生活方式改变和药物治疗无反应的成人不受控制的高血压。 ReCor Medical 的装置使用超音波能量来去除肾动脉周围的交感神经，从而减少与高血压相关的过度活动。临床研究表明血压显着降低，从而获得了 FDA 的批准。这为努力控制血压的患者带来了新的希望。

高血压盛行率上升

高血压，特别是抗药性高血压盛行率的上升，大大推动了对肾臟去神经系统的需求。随着全世界高血压病例的增加，许多患者对传统药物没有足够的反应。根据世界卫生组织（WHO）发布的报告，全球估计有12.8亿30-79岁的成年人患有高血压，其中三分之二生活在低收入和中等收入国家。大约 46% 的成人高血压患者不知道自己的病情，只有 42% 的人得到诊断和治疗。大约 21% 的成年人的高血压得到控制。高血压是全球过早死亡的主要原因。这就迫切需要替代疗法，例如肾去神经术，它透过针对肾臟神经来降低血压提供了一个有前景的解决方案。随着全球高血压负担的增加，采用有效、创新的治疗方法（例如去肾神经术）的紧迫性不断增强，从而促进了去肾神经系统市场的成长。

技术进步

肾臟去神经术的技术进步透过提高疗效和安全性正在彻底改变治疗方案。基于导管的技术创新正在提高精确度并降低手术风险，使肾去神经术更容易被更广泛的患者群体所接受。非侵入性技术也越来越受到关注，提供了潜在的好处，例如缩短恢復时间和最小化患者不适。这些进步对于吸引更多的临床采用至关重要，因为医疗保健提供者寻求可靠且有效的解决方案来管理高血压和抗药性高血压，从而推动肾臟去神经术市场的成长。例如，2024 年 6 月，韩国医疗科技公司 DeepQure 启动了一项早期可行性研究，以评估其肾臟去神经装置 HyperQure 用于治疗顽固性高血压。这项研究涉及美国医院的 15 名患者，先前 FDA 批准了研究设备豁免。该装置能够消融肾交感神经而不损伤血管内皮，使其在市场上脱颖而出。该公司的目标是继这一监管里程碑之后推进全球临床试验。

去肾神经系统市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品类型、产品、技术、应用和最终用户对市场进行了分类。

按产品类型划分：

导管

单电极导管

多电极导管

射频发生器

神经调节剂

导管占据大部分市场份额

该报告根据产品类型对市场进行了详细的细分和分析。这包括导管（单电极导管、多电极导管）、射频产生器和神经调节剂。根据该报告，导管占最大部分。

导管在肾去神经系统市场份额中占据主导地位，这主要是因为它们在直接向肾神经提供治疗干预方面发挥着重要作用。这些设备可以针对交感神经进行微创手术，这对于调节血压至关重要。先进的导管技术，包括基于射频和超音波的系统，可在扰乱神经活动方面提供精确的控制和功效，同时确保患者的安全。基于导管的肾去神经术的越来越多的采用反映了它们在治疗抗药性高血压和改善患者预后方面的有效性。例如，2024 年 3 月，FDA 批准了两种新型微创导管式肾臟去神经装置，用于帮助患有持续性高血压的患者。这些设备针对交感神经来降低血压，可能减少对某些抗高血压药物的需求。随着创新不断增强导管设计和手术技术，它们有望在不断发展的高血压治疗领域中保持突出地位。

按产品划分：

简单性

维斯克斯 (V2)

英利格HTN

天堂

伊贝里斯

其他的

Symplicity 占据业界最大份额

报告还提供了基于该产品的详细市场细分和分析。这包括 Symplicity、Vessix (V2)、EnligHTN、Paradise、Iberis 等。报告显示，Symplicity 占据了最大的市场份额。

Symplicity 在肾去神经系统行业中占有最大份额，这主要是因为它在开发基于导管的高血压治疗技术方面发挥了先锋作用。 Symplicity 系统以其利用射频能量破坏肾臟神经活动的功效而闻名，基于支持其有效性的临床证据，已经建立了强大的市场地位。 2023 年 11 月，FDA 批准美敦力的 Symplicity 肾臟去神经系统用于治疗高血压。该系统采用基于导管的方法，透过射频能量对肾动脉进行去神经支配。临床试验表明，接受该装置的患者动态收缩压显着降低。该批准为结合药物和生活方式改变的高血压治疗提供了一个有前途的替代方案。这一领先地位得到了持续的研究和开发工作的进一步巩固，这些研究和开发工作旨在增强设备功能和扩大适应症，从而加强 Symplicity 在不断发展的肾去神经疗法领域的主导地位。

按技术划分：

超音波消融

射频消融术

微量输液

射频消融术代表领先的细分市场

该报告基于该技术对市场进行了详细的细分和分析。这包括超音波消融、射频消融和微输注。根据该报告，射频消融占据了最大的部分。

射频消融确实是去肾神经系统市场的领先领域。该技术涉及使用射频能量消融或停用肾神经，这有助于降低高血压。与手术方法相比，它因其有效性和相对非侵入性而受到关注。射频消融系统通常使用配备电极的导管将受控热能传递到肾臟神经，从而破坏其功能。根据休士顿卫理公会发表的一篇文章，突破性的肾臟去神经术为慢性或难治性高血压带来了新的希望。这种微创手术利用射频消融来破坏血压升高的讯号，从而提供潜在的长期缓解。该细分市场的成长是由导管技术的进步、支持其功效的临床证据的增加以及为改善治疗抗药性高血压的手术结果和患者安全而进行的持续创新所推动的。

按应用划分：

高血压

心臟疾病

糖尿病

肾衰竭

其他的

报告还提供了基于应用程式的详细市场细分和分析。这包括高血压、心臟病、糖尿病、肾衰竭等。

肾臟去神经系统主要用于治疗高血压，特别是传统药物无效的顽固性高血压。透过瞄准和破坏导致血压升高的肾臟神经，这些系统为降低血压提供了创新的解决方案。该应用程式因其提供非药物治疗选择、改善患者预后并降低与不受控制的高血压相关的心血管事件风险的潜力而受到广泛关注。

在心臟病的情况下，肾臟去神经系统透过减少交感神经系统活动来帮助治疗心臟衰竭和心房颤动等疾病。这种减少可以减轻心臟的压力，改善心臟功能，并有可能预防心律不整。在心臟疾病中使用肾去神经术是一个新兴领域，透过解决神经对这些疾病的影响并增强整体心血管健康，提供了有前景的益处。

去肾神经系统也正在探索其在治疗糖尿病方面的潜在益处。透过调节交感神经系统，这些系统可以改善胰岛素敏感性和葡萄糖代谢。该应用程式可以帮助儘管接受药物治疗但仍难以控制血糖的糖尿病患者，提供一种创新方法来管理糖尿病相关併发症并增强整体代谢健康。

对于肾衰竭患者，肾去神经系统旨在透过减少肾神经的过度活动来改善肾功能，肾神经的过度活动会加剧肾臟损伤。该应用的重点是减慢性肾臟疾病的进展并改善肾臟结果。透过针对导致肾功能障碍的潜在神经机制，这些系统为管理肾衰竭并可能改善受影响患者的生活品质提供了一种新的治疗途径。

按最终用户划分：

诊断中心和医院

门诊护理中心

其他的

诊断中心和医院主导市场

该报告提供了基于最终用户的详细市场细分和分析。这包括诊断中心和医院、门诊护理中心等。根据该报告，诊断中心和医院占最大部分。

诊断中心和医院凭藉其先进的医疗基础设施和管理高血压及相关疾病的专业知识，在肾臟去神经系统市场中占据主导地位。这些机构配备了必要的技术和熟练的专业人员，可以安全有效地进行肾臟去神经术手术。此外，医院和诊断中心提供的全面病患照护可确保彻底的术前评估和术后监测，从而提高病患的治疗效果。它们在医疗保健服务中的核心作用使它们成为部署去肾神经技术、推动市场成长和这些创新治疗方法采用的主要场所。

按地区划分：

北美洲

美国

加拿大

亚太地区

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

欧洲引领市场，占据最大的去肾神经系统市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。根据报告，欧洲是去肾神经系统最大的区域市场。

由于先进的医疗基础设施、广泛的临床研究和有利的监管环境，欧洲引领市场，占据最大的去肾神经系统市场份额。该地区对创新医疗技术的重视和高血压的高盛行率推动了肾去神经术的采用。德国、法国和英国等欧洲国家拥有健全的医疗保健系统，有助于先进治疗的实施。根据IEA发布的报告，德国医疗保健市场至关重要，医疗技术市场每年价值约420亿美元。医疗保健产业在德国经济中发挥着举足轻重的作用，占德国 GDP 的 12%。德国医疗设备市场以欧元计算的复合年增长率预计为 5.1%，以美元计算为 6.8%，呈现成长机会。美国供应商有潜力参与医疗保健基础设施和创新项目。此外，政府措施的大力支持和医疗保健研究投资的增加有助于欧洲在肾臟去神经术市场中占据主导地位。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。去肾神经系统产业的一些主要市场参与者包括 Boston Scientific Group、Kona Medical Inc.、Medtronic Plc、Mercator MedSystems、ReCor Medical Inc.（Otsuka Holdings Co. Ltd.）、Renal Dynamics、St. Jude Medical Inc.。 （雅培）和泰尔茂公司。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

肾臟去神经系统市场竞争激烈，美敦力 (Medtronic)、波士顿科学 (Boston Scientific) 和 ReCor Medical 等主要参与者在创新和市场份额方面处于领先地位。这些公司专注于技术进步、广泛的临床试验和策略合作伙伴关係，以增强其产品组合和市场覆盖范围。例如，2024年5月，美敦力的Symplicity Spyral肾去神经术（RDN）系统获得国家药品监督管理局（NMPA）批准在中国商业化使用。该系统旨在解决高血压这一中国的主要健康问题，并具有显着降低血压的潜力。继最近 FDA 批准并在印度和加拿大推出后，这项批准增加了该设备在全球 70 多个国家的可用性。新兴企业也以新颖的解决方案和微创技术进入市场，竞争压力不断增加。持续的研发工作和监管审批对于在这个快速发展的市场中保持竞争优势发挥着至关重要的作用。

去肾神经系统市场新闻：

2024年6月，波士顿科学公司宣布以约11.6亿美元收购Silk Road Medical, Inc.。 Silk Road Medical 的创新经颈动脉血管重建 (TCAR) 平台透过微创手术帮助颈动脉疾病患者预防中风。此次收购增强了波士顿科学公司的血管产品组合，并表明该公司致力于为周围血管疾病提供先进的解决方案。该交易预计将于 2024 年下半年完成，具体取决于惯例成交条件。

2024 年 6 月，NexJ Health 和 Kona Medical Consulting 宣布结成策略联盟，以转变医生群体基于价值的照护。透过将 NexJ 的虚拟健康计划与 Kona 的管理服务组织专业知识相结合，该联盟旨在加强患者护理、提高营运效率并满足监管要求。此次合作开创了基于价值的护理的新时代，为全国的医生团体提供了整合技术、专业知识和以患者为中心的整体解决方案。

本报告回答的关键问题：

  • 迄今为止，全球肾臟去神经系统市场表现如何，未来几年将如何表现？
  • 全球去肾神经系统市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球去肾神经系统市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的肾去神经系统市场？
  • 依产品类型分類的市场是怎么样的？
  • 去肾神经系统市场中哪种产品类型最具吸引力？
  • 基于产品的市场区隔是什么？
  • 去肾神经系统市场中哪一款产品最具吸引力？
  • 基于技术的市场区隔是什么？
  • 去肾神经系统市场中哪一项技术最具吸引力？
  • 基于应用的市场区隔是什么？
  • 肾臟去神经系统市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 去肾神经系统市场中哪个是最具吸引力的最终用户？
  • 市场按地区划分是怎样的？
  • 去肾神经系统市场哪个区域最具吸引力？
  • 市场竞争结构如何？
  • 全球去肾神经系统市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球肾臟去神经系统市场表现如何，未来几年将如何表现？
  • 全球去肾神经系统市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球去肾神经系统市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的肾去神经系统市场？
  • 依产品类型分類的市场是怎么样的？
  • 去肾神经系统市场中哪种产品类型最具吸引力？
  • 基于产品的市场区隔是什么？
  • 去肾神经系统市场中哪种产品最具吸引力？
  • 基于技术的市场区隔是什么？
  • 去肾神经系统市场中哪一项技术最具吸引力？
  • 基于应用的市场区隔是什么？
  • 去肾神经系统市场哪一个应用最吸引人？
  • 基于最终用户的市场区隔是什么？
  • 去肾神经系统市场中哪个是最具吸引力的最终用户？
  • 市场按地区划分是怎样的？
  • 去肾神经系统市场哪个区域最具吸引力？
  • 市场竞争结构如何？
  • 全球去肾神经系统市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球去肾神经系统市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 导管
    • 市场趋势
    • 主要类型
      • 单电极导管
      • 多电极导管
    • 市场预测
  • 射频发生器
    • 市场趋势
    • 市场预测
  • 神经调节剂
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依产品

  • 简单性
    • 市场趋势
    • 市场预测
  • 维斯克斯 (V2)
    • 市场趋势
    • 市场预测
  • 英利格HTN
    • 市场趋势
    • 市场预测
  • 天堂
    • 市场趋势
    • 市场预测
  • 伊贝里斯
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依技术

  • 超音波消融
    • 市场趋势
    • 市场预测
  • 射频消融术
    • 市场趋势
    • 市场预测
  • 微量输液
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按应用

  • 高血压
    • 市场趋势
    • 市场预测
  • 心臟疾病
    • 市场趋势
    • 市场预测
  • 糖尿病
    • 市场趋势
    • 市场预测
  • 肾衰竭
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 诊断中心和医院
    • 市场趋势
    • 市场预测
  • 门诊护理中心
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boston Scientific Group
    • Kona Medical Inc.
    • Medtronic Plc
    • Mercator MedSystems
    • ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
    • Renal Dynamics
    • St. Jude Medical Inc. (Abbott)
    • Terumo Corporation
Product Code: SR112024A2558

The global renal denervation systems market size reached US$ 443.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,077.3 Million by 2032, exhibiting a growth rate (CAGR) of 32.7% during 2024-2032. The market is driven by the rising prevalence of hypertension, technological advancements in treatment methods, and extensive clinical trials demonstrating efficacy. Hospitals and diagnostic centers are widely adopting these systems, which, along with strategic collaborations and regulatory approvals are further fuelingl market growth.

Renal Denervation Systems Market Analysis:

Major Market Drivers: The market is mainly driven by the rising incidence of hypertension and drug resistant hypertension which drives the demand for effective treatments. Technological advancements in catheter based and non-invasive methods enhances the treatment efficiency and safety thereby fostering the adoption. Extensive clinical trials validating long term benefits further boost the market growth. The growing emphasis on improving patient outcomes and managing chronic conditions underscores the renal denervation systems market growth.

Key Market Trends: Key market trends include various technological innovations like advanced catheter-based systems and non-invasive systems which improves the overall efficacy and safety. Gradual increase in clinical trials is validating long term benefits further fostering the wider acceptance. Approvals are accelerating the market entry while strategic collaborations are enhancing the research and development efforts. The rising incidence of hypertension is also contributing positively to the renal denervation systems market growth.

Geographical Trends: Geographical trends in the market shows significant adoption and growth in Europe generally driven by their advanced healthcare infrastructure and favorable regulatory environments. North America is also expanding gradually mainly due to the rising prevalence of hypertension and various technological advancements. The Asia Pacific is witnessing a significant increase in market activity due to the growing healthcare investments and rising awareness among consumers. Latin America and Middle East are emerging markets with potential for growth as healthcare systems.

Competitive Landscape: Some of the major market players in the renal denervation systems industry include Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporation, among many others.

Challenges and Opportunities: The market faces various challenges like high costs, regulatory hurdles and the need for extensive clinical trials. However, it also presents opportunities such as technological advancements, increasing demand due to the rise in drug-resistant hypertension, and expanding healthcare infrastructure in emerging markets. Strategic collaborations and favorable regulatory developments further enhance growth potential, while rising awareness about renal denervation benefits can drive the renal denervation systems market growth and penetration globally.

Renal Denervation Systems Market Trends:

Rising Clinical Trials

Increasing clinical trials are pivotal for the renal denervation market as they provide essential data on the long-term benefits and safety of the procedure. These trials help establish the efficacy of renal denervation in managing hypertension, thereby gaining confidence among healthcare providers and patients. Successful trial outcomes lead to regulatory approvals, thereby further driving the product adoption. Additionally, clinical trials foster innovation by highlighting areas for improvement and validating new technologies, ultimately supporting market growth and expansion. For instance, in November 2023, FDA approved an ultrasound renal denervation device, the Paradise system, for treating uncontrolled hypertension in adults not responding to lifestyle changes and medications. The device by ReCor Medical uses ultrasound energy to denervate sympathetic nerves surrounding the renal arteries reducing hypertension-related overactivity. Clinical studies demonstrated a significant reduction in blood pressure leading to the FDA's approval. This offers new hope for patients struggling to control their blood pressure.

Rising Prevalence of Hypertension

The rising prevalence of hypertension, particularly drug-resistant hypertension, is significantly driving the demand for renal denervation systems. With increasing cases of hypertension worldwide, many patients do not respond adequately to traditional medications. According to the report published by the World Health Organization (WHO), an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension with two-thirds living in low- and middle-income countries. Approximately 46% of adults with hypertension are unaware of their condition and only 42% are diagnosed and treated. Around 21% of adults have their hypertension under control. Hypertension is a major cause of premature death globally. This creates a pressing need for alternative treatments like renal denervation, which offers a promising solution by targeting the renal nerves to lower blood pressure. As the global burden of hypertension grows, the urgency to adopt effective, innovative treatments such as renal denervation continues to intensify, boosting renal denervation systems market growth.

Technological Advancements

Technological advancements in renal denervation are revolutionizing treatment options by enhancing both efficacy and safety profiles. Innovations in catheter-based techniques are improving precision and reducing procedural risks, making renal denervation more accessible to a broader patient base. Non-invasive technologies are also gaining traction, offering potential benefits such as reduced recovery times and minimal patient discomfort. These advancements are crucial in attracting greater clinical adoption as healthcare providers seek reliable and efficient solutions for managing hypertension and drug-resistant hypertension, thereby driving growth in the renal denervation market. For instance, in June 2024, South Korean medtech firm DeepQure initiated an Early Feasibility Study to assess its renal denervation device, HyperQure, for treating resistant hypertension. The study, involving 15 patients across US hospitals, follows FDA approval for investigational device exemption. The device's ability to ablate renal sympathetic nerves without damaging the vascular endothelium distinguishes it in the market. The company aims to advance global clinical trials following this regulatory milestone.

Renal Denervation Systems Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, product, technology, application and end user.

Breakup by Product Type:

Catheters

Single Electrode Catheter

Multi Electrode Catheter

RF Generator

Nerve Modifying Agents

Catheters accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes catheters (single electrode catheter, multi electrode catheter), RF generator and nerve modifying agents. According to the report, catheters represented the largest segment.

Catheters dominate the renal denervation systems market share, primarily due to their essential role in delivering therapeutic interventions directly to renal nerves. These devices enable minimally invasive procedures that target sympathetic nerves, crucial for regulating blood pressure. Advanced catheter technologies, including radiofrequency and ultrasound-based systems, offer precise control and efficacy in disrupting nerve activity while ensuring patient safety. The increasing adoption of catheter-based renal denervation reflects their effectiveness in treating drug-resistant hypertension and improving patient outcomes. For instance, in March 2024, two new minimally invasive catheter-based renal denervation devices have been approved by the FDA to help people with persistent hypertension. These devices target sympathetic nerves to lower blood pressure, potentially reducing the need for some antihypertensive medications. As innovations continue to enhance catheter designs and procedural techniques, they are expected to maintain their prominent position in the evolving landscape of hypertension management.

Breakup by Product:

Symplicity

Vessix (V2)

EnligHTN

Paradise

Iberis

Others

Symplicity holds the largest share of the industry

A detailed breakup and analysis of the market based on the product have also been provided in the report. This includes Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis and others. According to the report, Symplicity accounted for the largest market share.

Symplicity holds the largest share of the renal denervation systems industry primarily due to its pioneering role in developing catheter-based technologies for treating hypertension. The Symplicity system, known for its efficacy in disrupting renal nerve activity using radiofrequency energy, has established a strong market presence based on clinical evidence supporting its effectiveness. In November 2023, FDA approves Medtronic's Symplicity Renal Denervation System to treat hypertension. The system uses a catheter-based approach to denervate the renal arteries with radiofrequency energy. Clinical trials showed a significant reduction in ambulatory systolic blood pressure in patients who received the device. The approval offers a promising alternative for hypertension treatment in combination with medication and lifestyle changes. This leadership position is further bolstered by ongoing research and development efforts aimed at enhancing device capabilities and expanding indications, reinforcing Symplicity's dominance in the evolving landscape of renal denervation therapies.

Breakup by Technology:

Ultrasound Ablation

Radiofrequency Ablation

Microinfusion

Radiofrequency Ablation represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the technology. This includes ultrasound ablation, radiofrequency ablation and microinfusion. According to the report, radiofrequency ablation represented the largest segment.

Radiofrequency ablation is indeed a leading segment in the renal denervation systems market. This technology involves using radiofrequency energy to ablate or deactivate renal nerves, which helps in reducing hypertension. It has gained prominence due to its effectiveness and relative non-invasiveness compared to surgical approaches. Radiofrequency ablation systems typically use catheters equipped with electrodes to deliver controlled thermal energy to the renal nerves, thereby disrupting their function. According to an article published by Houston Methodist, a groundbreaking renal denervation procedure offers new hope for chronic or treatment-resistant hypertension. The minimally invasive procedure disrupts blood pressure-elevating signals using radiofrequency ablation, providing potential long-term relief. This segment's growth is driven by advancements in catheter technology, increasing clinical evidence supporting its efficacy, and ongoing innovations to improve procedural outcomes and patient safety in treating drug-resistant hypertension.

Breakup by Application:

Hypertension

Cardiac Disorders

Diabetes

Renal Failure

Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes hypertension, cardiac disorders, diabetes, renal failure and others.

Renal denervation systems are primarily used to treat hypertension, especially resistant hypertension where traditional medications are ineffective. By targeting and disrupting renal nerves that contribute to elevated blood pressure, these systems provide an innovative solution for lowering blood pressure. This application has gained significant attention due to its potential to offer a non-pharmacological treatment option, improving patient outcomes and reducing the risk of cardiovascular events associated with uncontrolled hypertension.

In the context of cardiac disorders, renal denervation systems help manage conditions like heart failure and atrial fibrillation by reducing sympathetic nervous system activity. This reduction can alleviate stress on the heart, improve cardiac function, and potentially prevent arrhythmias. The use of renal denervation in cardiac disorders is an emerging field, offering promising benefits by addressing the neural contributions to these conditions and enhancing overall cardiovascular health.

Renal denervation systems are also being explored for their potential benefits in managing diabetes. By modulating the sympathetic nervous system, these systems may improve insulin sensitivity and glucose metabolism. This application could help diabetic patients who struggle with blood sugar control despite medication, offering an innovative approach to managing diabetes-related complications and enhancing overall metabolic health.

For patients with renal failure, renal denervation systems aim to improve kidney function by reducing the overactivity of renal nerves that can exacerbate kidney damage. This application focuses on slowing the progression of chronic kidney disease and improving renal outcomes. By targeting the underlying neural mechanisms contributing to renal dysfunction, these systems offer a novel therapeutic avenue for managing renal failure and potentially improving quality of life for affected patients.

Breakup by End User:

Diagnostic Centers and Hospitals

Ambulatory Care Centers

Others

Diagnostic Centers and Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes diagnostic centers and hospitals, ambulatory care centers and others. According to the report, diagnostic centers and hospitals represented the largest segment.

Diagnostic centers and hospitals dominate the renal denervation systems market due to their advanced medical infrastructure and expertise in managing hypertension and related conditions. These institutions are equipped with the necessary technology and skilled professionals to perform renal denervation procedures safely and effectively. Additionally, the comprehensive patient care provided by hospitals and diagnostic centers ensures thorough pre-procedure assessments and post-procedure monitoring, enhancing patient outcomes. Their central role in healthcare delivery makes them the primary settings for deploying renal denervation technologies, driving market growth and adoption of these innovative treatments.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Europe leads the market, accounting for the largest renal denervation systems market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe represents the largest regional market for renal denervation systems.

Europe leads the market, holding the largest renal denervation systems market share due to advanced healthcare infrastructure, extensive clinical research, and favorable regulatory environments. The region's emphasis on innovative medical technologies and high prevalence of hypertension drives the adoption of renal denervation procedures. European countries like Germany, France, and the UK have robust healthcare systems that facilitate the implementation of advanced treatments. According to the report published by IEA, the German healthcare market is crucial, with a medical technology market valued at approximately $42 billion annually. The healthcare sector plays a pivotal role in the country's economy, representing 12% of Germany's GDP. With an expected CAGR of 5.1% in Euro-terms and 6.8% in USD-terms, the German medical equipment market presents opportunities for growth. U.S. suppliers have potential to engage in healthcare infrastructure and innovation projects. Moreover, strong support from government initiatives and increased investment in healthcare research contribute to Europe's dominant position in the renal denervation market.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the renal denervation systems industry include Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The Renal Denervation Systems market is highly competitive, with key players such as Medtronic, Boston Scientific, and ReCor Medical leading innovation and market share. These companies focus on technological advancements, extensive clinical trials, and strategic partnerships to enhance their product portfolios and market reach. For instance, in May 2024, Medtronic's Symplicity Spyral renal denervation (RDN) system was approved for commercial use in China by the National Medical Products Administration (NMPA). The system aims to address hypertension, a major health concern in China, with the potential for significant blood pressure reduction. This approval adds to the device's availability in over 70 countries globally, following recent FDA approval and launch in India and Canada. Emerging players are also entering the market with novel solutions and minimally invasive technologies, increasing competitive pressure. Continuous R&D efforts and regulatory approvals play crucial roles in maintaining a competitive edge in this rapidly evolving market.

Renal Denervation Systems Market News:

In June 2024, Boston Scientific announced the acquisition of Silk Road Medical, Inc. for approximately $1.16 billion. Silk Road Medical's innovative transcarotid artery revascularization (TCAR) platform helps prevent strokes in patients with carotid artery disease through a minimally invasive procedure. The acquisition enhances Boston Scientific's vascular portfolio and demonstrates the company's dedication to providing advanced solutions for peripheral vascular disease. The transaction is expected to be completed in the second half of 2024, subject to customary closing conditions.

In June 2024, NexJ Health and Kona Medical Consulting announced a strategic alliance to transform value-based care for physician groups. By combining NexJ's virtual health programs with Kona's managed service organization expertise, the alliance aims to enhance patient care, improve operational efficiency, and address regulatory requirements. This collaboration introduces a new era in value-based care, offering a holistic solution that integrates technology, expertise, and patient-centricity for physician groups nationwide.

Key Questions Answered in This Report:

  • How has the global renal denervation systems market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global renal denervation systems market?
  • What is the impact of each driver, restraint, and opportunity on the global renal denervation systems market?
  • What are the key regional markets?
  • Which countries represent the most attractive renal denervation systems market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the renal denervation systems market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the renal denervation systems market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the renal denervation systems market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the renal denervation systems market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the renal denervation systems market?
  • What is the breakup of the market based on the region?
  • Which is the most attractive region in the renal denervation systems market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global renal denervation systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Denervation Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Catheters
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Single Electrode Catheter
      • 6.1.2.2 Multi Electrode Catheter
    • 6.1.3 Market Forecast
  • 6.2 RF Generator
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Nerve Modifying Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Symplicity
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Vessix (V2)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 EnligHTN
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Paradise
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Iberis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Ultrasound Ablation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Radiofrequency Ablation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Microinfusion
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Hypertension
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cardiac Disorders
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diabetes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Renal Failure
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Diagnostic Centers and Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ambulatory Care Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Boston Scientific Group
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Kona Medical Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Medtronic Plc
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Mercator MedSystems
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Renal Dynamics
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 St. Jude Medical Inc. (Abbott)
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Terumo Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Renal Denervation Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Denervation Systems Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Renal Denervation Systems Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Renal Denervation Systems Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Renal Denervation Systems Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Renal Denervation Systems Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Renal Denervation Systems Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Renal Denervation Systems Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Renal Denervation Systems (Catheters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Renal Denervation Systems (Catheters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Renal Denervation Systems (RF Generator) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Renal Denervation Systems (RF Generator) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Renal Denervation Systems (Nerve Modifying Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Renal Denervation Systems (Nerve Modifying Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Renal Denervation Systems (Symplicity) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Renal Denervation Systems (Symplicity) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Renal Denervation Systems (Vessix- V2) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Renal Denervation Systems (Vessix- V2) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Renal Denervation Systems (EnligHTN) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Renal Denervation Systems (EnligHTN) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Renal Denervation Systems (Paradise) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Renal Denervation Systems (Paradise) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Renal Denervation Systems (Iberis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Renal Denervation Systems (Iberis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Renal Denervation Systems (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Renal Denervation Systems (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Renal Denervation Systems (Ultrasound Ablation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Renal Denervation Systems (Ultrasound Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Renal Denervation Systems (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Renal Denervation Systems (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Renal Denervation Systems (Microinfusion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Renal Denervation Systems (Microinfusion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Renal Denervation Systems (Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Renal Denervation Systems (Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Renal Denervation Systems (Cardiac Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Renal Denervation Systems (Cardiac Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Renal Denervation Systems (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Renal Denervation Systems (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Renal Denervation Systems (Renal Failure) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Renal Denervation Systems (Renal Failure) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Renal Denervation Systems (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Renal Denervation Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Renal Denervation Systems (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Renal Denervation Systems (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Renal Denervation Systems (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Renal Denervation Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: North America: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: North America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United States: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United States: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Canada: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Canada: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Asia Pacific: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Asia Pacific: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: China: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: China: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Japan: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Japan: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: India: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: India: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: South Korea: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: South Korea: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Australia: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Australia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Indonesia: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Indonesia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Europe: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Europe: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Germany: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Germany: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: France: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: France: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: United Kingdom: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: United Kingdom: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Italy: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Italy: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Spain: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Spain: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Russia: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Russia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Latin America: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Latin America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Brazil: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Brazil: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Mexico: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Mexico: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Middle East and Africa: Renal Denervation Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Middle East and Africa: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Global: Renal Denervation Systems Industry: SWOT Analysis
  • Figure 99: Global: Renal Denervation Systems Industry: Value Chain Analysis
  • Figure 100: Global: Renal Denervation Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Denervation Systems Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Renal Denervation Systems Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Renal Denervation Systems Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Renal Denervation Systems Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Renal Denervation Systems Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Renal Denervation Systems Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Renal Denervation Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Renal Denervation Systems Market Structure
  • Table 9: Global: Renal Denervation Systems Market: Key Players